Pharma Companies Welcome New Year With 583 Drug Price Hikes so Far
Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference
Zentalis Pharma Says FDA Grants Fast Track Status on Azenosertib Cancer Drug Candidate
Drugs Not Selected for Medicare Price Negotiation Nearly Doubled - Report
Pfizer Inc. (NYSE:PFE) Is Largely Controlled by Institutional Shareholders Who Own 68% of the Company
Daily short sale tracking: IonQ Inc's short volume increased by 9 million, with a short sale ratio of 9%
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
